FDA approves Boston Scientific pacemakers

Natick medical device maker Boston Scientific Corp. today announced the Food and Drug Administration's approval of a new family of advanced pacemakers called Altrua.

The announcement comes a day after Boston Scientific said that the product line was approved by European regulators.

The company said that this is the first Boston Scientific-branded pacemaker to treat bradycardia, a condition in which the heart beats too slowly.

In addition, Altrua pacemakers deliver enhanced therapies while maintaining a small size and battery longevity, Boston Scientific said.
(By Chris Reidy, Globe staff)

•  Previous Entry
• Next Entry